Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 119,709 | 98,841 | 122,948 | 329,633 | 409,852 |
| Marketable Securities | 173,421 | 144,258 | 135,677 | N/A | N/A |
| Receivables | 51,218 | 38,302 | 23,476 | 17,282 | 12,759 |
| Inventories | 8,135 | 7,942 | 3,980 | 2,021 | 2,217 |
| TOTAL | $360,154 | $295,635 | $292,288 | $353,743 | $429,594 |
| Non-Current Assets | |||||
| PPE Net | 51,122 | 25,433 | 14,315 | 9,501 | 7,102 |
| Other Non-Current Assets | 119,959 | 132,272 | 140,726 | 99,328 | 2,632 |
| TOTAL | $171,081 | $157,705 | $155,041 | $108,829 | $9,734 |
| Total Assets | $531,235 | $453,340 | $447,329 | $462,572 | $439,328 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 278 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,901 | 10,268 | 4,731 | 2,546 | 2,098 |
| Accrued Expenses | 32,555 | 28,945 | 24,358 | 15,483 | 9,108 |
| Other current liabilities | N/A | N/A | N/A | N/A | 6,615 |
| TOTAL | $49,392 | $47,667 | $36,128 | $24,886 | $20,876 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,745 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 14,656 | 14,198 | 11,623 | 25,187 | 1,735 |
| TOTAL | $26,008 | $14,404 | $12,051 | $25,946 | $2,761 |
| Total Liabilities | $75,400 | $62,071 | $48,179 | $50,832 | $23,637 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,514 | 27,450 | 26,576 | 25,411 | 24,978 |
| Common Shares | 28 | 27 | 27 | 25 | 25 |
| Retained earnings | -200,126 | -218,371 | -160,905 | -93,767 | -62,496 |
| Other shareholders' equity | 230 | 136 | -381 | 0 | 0 |
| TOTAL | $455,835 | $391,269 | $399,150 | $411,740 | $415,691 |
| Total Liabilities And Equity | $531,235 | $453,340 | $447,329 | $462,572 | $439,328 |